Matrix metalloproteinases activities in hypertension: emerging opportunities.

about

Molecular targets of antihypertensive peptides: understanding the mechanisms of action based on the pathophysiology of hypertension Matrix metalloproteinases as drug targets in preeclampsia Metalloproteinases in hypertension and cardiac disease: differential expression and mutual regulation.

P2860

Q35016422-40A96DC6-1E87-4DF0-88F2-CEE358744C46 Q36910638-4FDA1A24-06D2-465A-BEA9-67AB08485EEF Q38224470-2B0EC9B4-51AB-472E-9A36-5F42B0229A73

P2860

Matrix metalloproteinases activities in hypertension: emerging opportunities.

Item

http://www.wikidata.org/entity/Q42773403

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Matrix metalloproteinases activities in hypertension: emerging opportunities.

@en

Matrix metalloproteinases activities in hypertension: emerging opportunities.

@nl

type

Item

label

Matrix metalloproteinases activities in hypertension: emerging opportunities.

@en

Matrix metalloproteinases activities in hypertension: emerging opportunities.

@nl

prefLabel

Matrix metalloproteinases activities in hypertension: emerging opportunities.

@en

Matrix metalloproteinases activities in hypertension: emerging opportunities.

@nl

P1476

Matrix metalloproteinases activities in hypertension: emerging opportunities.

@en

P2093

Geert W Schmid-Schönbein

http://www.w3.org/2001/XMLSchema#string

P2860

Matrix metalloproteinases cleave the beta2-adrenergic receptor in spontaneously hypertensive rats.

MT1-MMP: a key regulator of cell migration in tissue.

Metalloproteinases and atherothrombosis: MMP-10 mediates vascular remodeling promoted by inflammatory stimuli.

Multiphasic roles for matrix metalloproteinases after stroke.

Matrix metalloproteinase-2 cleavage of adrenomedullin produces a vasoconstrictor out of a vasodilator.

Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension.

Matrix metalloproteinase-7 and ADAM-12 (a disintegrin and metalloproteinase-12) define a signaling axis in agonist-induced hypertension and cardiac hypertrophy.

Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis.

MMP-2 mediates angiotensin II-induced hypertension under the transcriptional control of MMP-7 and TACE.

P304

24-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1161/HYPERTENSIONAHA.110.162032

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21079046

http://www.w3.org/2001/XMLSchema#string

P932

4123869

http://www.w3.org/2001/XMLSchema#string

Matrix metalloproteinases activities in hypertension: emerging opportunities.

about

P2860

P2860

Matrix metalloproteinases activities in hypertension: emerging opportunities.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932